Doxorubicin and Topotecan for Relapsed/Refractory Small Cell Lung Cancer (SCLC): A FPBCC Clinical Trials Network Phase I Study

被引：0
|
作者：
Umakanthan, J. Manikkam [1 ]
Marr, A. [1 ]
Ernani, V. [1 ]
Kessinger, M. [1 ]
Smith, L. [2 ]
Tijerina, J. [1 ]
Radniecki, S. [1 ]
Kosmacek, E. [1 ]
Ketcham, M. [1 ]
Ganti, A. K. [3 ,4 ]
机构：
[1] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Div Hematol & Oncol, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
[3] Va Nebraska Western Iowa Hlth Care Syst, Div Hematol & Oncol, Omaha, NE USA
[4] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
small cell lung cancer; topotecan; Doxorubicin;
D O I：
10.1016/j.jtho.2017.09.1406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.15-013
引用
收藏
页码：S2188 / S2188
页数：1
相关论文
共 50 条
  • [31] Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
    Gelsomino, Francesco
    Tiseo, Marcello
    Barbieri, Fausto
    Riccardi, Ferdinando
    Cavanna, Luigi
    Frassoldati, Antonio
    Delmonte, Angelo
    Longo, Lucia
    Dazzi, Claudio
    Cinieri, Saverio
    Colantonio, Ida
    Sperandi, Francesca
    Lamberti, Giuseppe
    Brocchi, Stefano
    Tofani, Lorenzo
    Boni, Luca
    Ardizzoni, Andrea
    BRITISH JOURNAL OF CANCER, 2020, 123 (01) : 26 - 32
  • [32] Topotecan in the treatment of relapsed small cell lung cancer
    Quoix, Elisabeth
    ONCOTARGETS AND THERAPY, 2008, 1 : 79 - 86
  • [33] Phase II trial of high-dose weekly topotecan in patients with relapsed small-cell lung cancer (SCLC)
    Shipley, D.
    Spigel, D. R.
    Hainsworth, J. D.
    Whorf, R. C.
    Markus, T. M.
    Kuzur, M.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A phase I study of amrubicin (AMR) and irinotecan (CPT-11) in relapsed small cell lung cancer(SCLC)
    Kawahara, M.
    Kubo, A.
    Komuta, K.
    Fukushima, M.
    Daimon, T.
    Furuse, K.
    Mio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer
    Shibayama, Takuo
    Hotta, Katsuyuki
    Takigawa, Nagio
    Tada, Atsuhiko
    Ueoka, Hiroshi
    Harita, Shingo
    Kiura, Katsuyuki
    Tabata, Masahiro
    Segawa, Yoshihiko
    Nogami, Naoyuki
    Kuyama, Shoichi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    LUNG CANCER, 2006, 53 (02) : 189 - 195
  • [36] NGR-HTNF IN COMBINATION WITH DOXORUBICIN IN RELAPSED SMALL-CELL LUNG CANCER (SCLC)
    Gregorc, V.
    Santoro, A.
    Novello, S.
    Grossi, F.
    Levra, M. Giaj
    Cavina, R.
    Vigano, M. G.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 149 - 150
  • [37] CLINICAL-TRIALS IN SMALL CELL LUNG-CANCER (SCLC)
    SOUHAMI, R
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 887 - 888
  • [38] Phase I study of topotecan and amrubicin in patients with chemo-naive extensive disease (ED) or relapsed small-call lung cancer (SCLC).
    Tabata, M
    Hotta, K
    Harita, S
    Segawa, Y
    Shibayama, T
    Kiura, K
    Shinkai, T
    Ueoka, H
    Tanimoto, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 705S - 705S
  • [39] A Phase I Study of Topotecan Plus Carboplatin for Relapsed SCLC WJTOG Trial
    Kurata, Takayasu
    Kashii, Tatsuhiko
    Takeda, Koji
    Seki, Nobuhiko
    Tsuboi, Masahiro
    Kobayashi, Masashi
    Satoh, Taroh
    Nakagawa, Kazuhiko
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (05) : 644 - 648
  • [40] Cisplatin plus topotecan plus paclitaxel weekly regimen in ovarian (OC) and small cell lung cancer (SCLC): A phase I study
    Frasci, G
    Comella, P
    Carteni, G
    Panza, N
    Tramontana, S
    Stellato, G
    Nicolella, GP
    Ruffolo, P
    Di Giacomo, S
    Iodice, F
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 104 - 104
12345